Siow Ming Lee
University College Hospital · 321 works · 23,954 citations · h-index 57
Top works
- Osimertinib in Untreated EGFR -Mutated Advanced Non–Small-Cell Lung Cancer
- Tracking the Evolution of Non–Small-Cell Lung Cancer
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
- Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma.
- Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
- Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
- COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
- Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data
- Lung adenocarcinoma promotion by air pollutants
- Inactivation of O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide
- Randomized Phase II Study of Docetaxel Versus Doxorubicin in First- and Second-Line Chemotherapy for Locally Advanced or Metastatic Soft Tissue Sarcomas in Adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
- Chemotherapy in non-small cell lung cancer
- O6-Methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma
- Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
- Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study
- Melanoma: chemotherapy
- Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma
- A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma
- Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors